Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FKBP prolyl isomerase 9 (FKBP9) is an enzyme of the immunophilin family, characterized by peptidyl-prolyl cis-trans isomerase activity and predicted calcium ion binding[5][1][4]. As a member of the FKBP protein family, FKBP9 is involved in regulating protein folding and may also play roles in calcium signaling within the cell[1][5][4]. While FKBP family members are established molecular targets for immunosuppressive drugs (such as tacrolimus and rapamycin), FKBP9 itself has not been directly associated with clinical therapeutic targeting or major disease roles[1][3][5]. The gene encoding FKBP9 is present on human chromosome 7[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FKBP prolyl isomerase 9 (FKBP9).